Metraipolis › archive › dc_f3ee9fe346db
Targeting SARS-CoV-2 main protease for the discovery of a broad-spectrum COVID-19 inhibitor by intensive multi-tiered validation — Europe PMC PMID:41311409
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41311409
- DOI
- 10.1016/j.apsb.2025.09.033
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T20:03:26.174Z
- SHA-256 of the archived text
baae81888132c6b603b92d4b80125bf85af91b9aa1a8e64c7daef779195652c2- Stable URL of this page
https://metraipolis.com/documento/dc_f3ee9fe346db
How to cite
Targeting SARS-CoV-2 main protease for the discovery of a broad-spectrum COVID-19 inhibitor by intensive multi-tiered validation — Europe PMC PMID:41311409 — Europe PMC (en), https://europepmc.org/article/MED/41311409 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f3ee9fe346db (Metraipolis archive dc_f3ee9fe346db, sha256 baae81888132c6b603b92d4b80125bf85af91b9aa1a8e64c7daef779195652c2)
BibTeX
@misc{dcf3ee9fe346db,
title = {Targeting SARS-CoV-2 main protease for the discovery of a broad-spectrum COVID-19 inhibitor by intensive multi-tiered validation — Europe PMC PMID:41311409},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41311409},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f3ee9fe346db; sha256 baae81888132c6b603b92d4b80125bf85af91b9aa1a8e64c7daef779195652c2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41311409. Agents can read the archived copy with the MCP tool read_document.